pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·19h ago·1 min read
save

Singapore moves forward with legislation for a more coherent, future-ready healthcare regulatory system

Sep 14, 2026·read at raps ↗RegulatoryPositive

Singapore's Parliament has taken a step toward overhauling its healthcare regulatory framework by advancing new legislation.

The proposed law aims to create a more coherent and future-ready system that offers clearer guidance and predictability for companies operating in the sector.

Officials say the changes are intended to support innovation and streamline approval processes, positioning Singapore as an attractive hub for pharma and biotech investment.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Asia-Pacific Roundup: Singapore advances legislation to build ‘more coherent, future-ready’ regulatory system”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Approval

related stories

  • Apr 28Rocket's PRV goes for $180M; Oruka targets $500M offeringEndpoints
  • Apr 28STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data neededSTAT
  • Apr 28FDA claims trial 'manipulation' tainted approval of ChemoCentryx drugEndpoints
  • Apr 28Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.BioPharma Dive
  • Apr 27Veradermics soars on positive data for baldness treatmentBioPharma Dive